Document Detail


Hormonal and cytokine effects of uric acid.
MedLine Citation:
PMID:  16340663     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Current evidence supports the role of soluble uric acid as a true mediator of injury, exerting its effects through the induction of growth factors, cytokines, hormones and autacoids. In the present review, we summarize recent studies on the mechanisms involved in the uric acid deleterious effects. RECENT FINDINGS: Although uric acid is considered an antioxidant in plasma, recent clinical and epidemiological studies have found that hyperuricemia is associated with mortality and development of hypertension, cardiovascular and chronic renal diseases. Experimental studies suggest that uric acid induce its detrimental effects at the cellular level entering to vascular smooth muscle cells (VSMC) via an organic anion transport system, and followed by the activation of specific MAP kinases, nuclear transcription factors, with stimulation of COX-2, PDGF A and C chain, PDGF alpha receptor, and various inflammatory mediators, including C-reactive protein and monocyte chemoattractant protein-1. Physiologically, these effects translate into a rise of arterial pressure, VSMC hypertrophy, tubulointerstitial infiltration and glomerular hypertension in the setting of renal vasoconstriction. Uric acid also promotes endothelial dysfunction through inactivation of NO and arresting the proliferation of endothelial cells. Thus, arteriosclerosis induced by hyperuricemia may be a novel mechanism for the development of essential hypertension. SUMMARY: Soluble uric acid has important biologic roles. While it acts as an antioxidant, there is also evidence that uric acid has pro-inflammatory and proliferative effects on VSMC, and causes dysfunction of endothelial cells. These cellular mechanisms may translate into why uric acid is associated with renal and cardiovascular disease.
Authors:
Laura G Sánchez-Lozada; Takahiko Nakagawa; Duk-Hee Kang; Dan I Feig; Martha Franco; Richard J Johnson; Jaime Herrera-Acosta
Related Documents :
4019023 - Hplc-studies on nonmercapt-mercapt conversion of human serum albumin.
16500353 - Uric acid crystals in the semen of a patient with symptoms of chronic prostatitis.
8732303 - Basic fibroblast growth factor and pdgf in gi diseases.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in nephrology and hypertension     Volume:  15     ISSN:  1062-4821     ISO Abbreviation:  Curr. Opin. Nephrol. Hypertens.     Publication Date:  2006 Jan 
Date Detail:
Created Date:  2005-12-12     Completed Date:  2006-04-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9303753     Medline TA:  Curr Opin Nephrol Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  30-3     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antioxidants / adverse effects*,  metabolism
Humans
Hyperuricemia / physiopathology*
Muscle, Smooth, Vascular / drug effects*
Uric Acid / adverse effects*,  metabolism
Vascular Diseases / etiology
Grant Support
ID/Acronym/Agency:
DK 52121/DK/NIDDK NIH HHS; HL 68607/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Antioxidants; 69-93-2/Uric Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardioprotective mechanisms of the kallikrein-kinin system in diabetic cardiopathy.
Next Document:  The renal medullary endothelin system in control of sodium and water excretion and systemic blood pr...